Aurora Cannabis (ACB) news

Aurora Cannabis: Co's special committee of board has not yet made a formal recommendation regarding Curaleaf offer

Aurora Cannabis Inc. (TSX: ACB) (NASDAQ: ACB) has formed a special committee of independent directors to evaluate the unsolicited take-over bid from Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF), but no formal recommendation has yet been made to shareholders. The Offer, which commenced on…

Aurora Cannabis buys Internode Pharma and Hap Pharma for GBP 2.1M

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) has announced the acquisition of Internode Pharma and Hap Pharma for a total consideration of GBP 2.1 million. The move is part of Aurora's ongoing strategy to expand its global medical cannabis platform and strengthen its presence in international…

Aurora Cannabis: Curaleaf's launch of takeover bid designed to "pressure" co shareholders into short-term decision for Curaleaf shareholders benefit

Aurora Cannabis urges holders to take no action at this time in respect to unsolicited takeover bid by Curaleaf Holdings

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) has advised its shareholders to take no action at this time regarding the unsolicited takeover bid proposed by Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF). The bid, which was formally announced on August 11, 2026, offers Aurora shareholders a…

Curaleaf launches take-over bid to acquire Aurora Cannabis, invites Aurora shareholders to tender to the bid